The CD38 protein is a prognostic marker of chronic lymphocytic leukemia and a therapeutic target in multiple myeloma, and has an established role as an immunomodulator in cancer [52]. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.